A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes

Condition(s) targeted: Diabetes Mellitus, Non-Insulin-Dependent

Intervention: Glucovance (metformin HCl/glyburide) (Drug); or Metformin HCl alone (Drug); or Glyburide alone. (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Bristol-Myers Squibb

The purpose of this clinical research study is to support earlier observations that Glucovance controls glucose levels after a mean, and improves overall glucose control better than metformin or glyburide therapy alone in adults with type 2 diabetes.

Study design: Treatment

Minimum age: 20 Years. Maximum age: 75 Years. Gender(s): Both.

Criteria:

Adults 20-75 with a diagnosis of type 2 diabetes mellitus who are not adequately controlled with diet and exercise, and have an HbA1c greater than 6. 7%

Local Institution, Little Rock, Arkansas, United States

Local Institution, Los Angeles, California, United States

Local Institution, Chicago, Illinois, United States

Local Institution, Indianapolis, Indiana, United States

Local Institution, Brooklyn, New York, United States

Local Institution, Rochester, New York, United States

Local Institution, Pittsburgh, Pennsylvania, United States

Local Institution, Dallas, Texas, United States

Local Institution, San Antonio, Texas, United States

BMS Clinical Trials Disclosure

For FDA Safety Alerts and Recalls refer to the following link www.fda.gov/MEDWATCH/safety.htm

Last updated: September 27, 2007